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The	   Interplay	  of	  Diabetes,	  and	  Health	  
Self	   Efficacy,	   Cognition	   and	  
Compliance	  
	  
Joseph	  Indelicato1,	  Vanessa	  Gilchriest1	  
	  
Globesity	   has	   partially	   been	   responsible	   for	   an	   outbreak	   of	  
diabetes	  which	   affects	   340	  million	  people	   in	   the	  world	   today1.	  
Severe	   diabetes,	   which	   would	   have	   killed	   a	   patient	   fifty	   years	  
ago,	  can	  now	  be	  managed	  for	  decades	  longer.	  So	  the	  number	  of	  
diabetics	   is	   increasing	   both	   among	   the	   obese	   young	   and	   the	  
elderly	   who	   live	   longer.	   Amongst	   diabetic	   adults,	   the	  
cardiovascular	   disease	   (CVD)	   death	   rate	   has	   declined	   by	   40%	  
(95%	   CI	   23–54),	   while	   the	   death	   rate	   from	   all	   other	   causes	  
declined	  by	  23%	  over	  a	  ten	  year	  period	  from	  1997	  to	  2006.	  	  	  Not	  
surprisingly	  therefore,	  the	  rate	  of	  diabetes	  and	  the	  concomitant	  
disorders	   continues	   to	   grow.	   Diabetes	   can	   also	   lead	   to	  
significant	   cognitive	   decline	   which	   leads	   to	   interference	   with	  
compliance,	  socialization	  and	  quality	  of	  life.	  Diabetes	  causes	  an	  
increase	   in	   cognitive	   impairment	   in	   vascular	   dementia.	   Type	   2	  
Diabetes	  may	  act	  as	  a	  partial	   causal	  agent	  of	   some	  dementias,	  
and	   the	   link	   between	   diabetes	   and	   Alzheimer’s	   has	   led	   a	  
number	  of	  researchers	  to	  claim	  Alzheimer’s	  is	  in	  reality	  a	  Type	  3	  
diabetes.	   	  A	  clear	  and	  statistically	   significant	   relationship	  exists	  
between	  HbA1c	  levels	  and	  the	  duration	  of	  diabetes	  mellitus	  and	  
cognitive	   dysfunction.	   While	   the	   causal	   mechanism	   remains	  
unknown	  Type	  2	  Diabetes	  clearly	   causes	  cognitive	   impairment.	  	  
This	  genetic	  predisposition	  to	  diabetes	  may	  be	  greatest	  amongst	  
South	  Asian	   Indians,	  and	   	  Hispanics.	  While	  genetics	   is	   certainly	  
not	  the	  sole	  determinant	  of	  diabetes,	  genetics	  likely	  plays	  a	  key	  
role.	  	  Some	  type	  of	  brief	  cognitive	  screening	  battery	  needs	  to	  be	  
developed	  to	  screen	  for	  Mild	  Cognitive	  Impairment,	  	  and	  Health	  
Self	  Efficacy,	  both	  of	  which	  affect	  compiance.	   	  This	   information	  
could	   be	   used	   to	   make	   treatment	   decisions,	   both	   in	   terms	   of	  
compliance	  and	  in	  terms	  of	  recommendations	  which	  may	  affect	  
an	   individual’s	   Quality	   of	   Life.	   With	   cognitive	   impairment	   and	  
low	  Health	  Self	  Efficacy	  due	  to	  diabetes,	  screening	  can	  be	  a	  key	  
tool	   in	   evaluating	   educational	   techniques	   which	   would	   	   aid	  
patients,	  their	  communities	  	  and	  their	  families	  as	  to	  the	  type	  of	  
interventions	  which	  may	  prove	  useful.	  
	  
OBESITY	  AND	  DIABETES:	  A	  GLOBAL	  HEALTH	  PROBLEM	  
Type	  2	  Diabetes	  currently	  affects	  over	  a	  third	  of	  a	  billion	  people	  
worldwide	   according	   to	   the	   World	   Health	   Organization	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estimates1.	   Estimates	   are	   that	   Diabetes	  
rates	   will	   continue	   to	   increase	   at	   a	   rapid	  
pace2.	   Diabetes,	   long	   characterized	   as	   a	  
chronic	  disease,	  has	  become	  more	  in	  recent	  
times	   and	   has	   become	   even	  more	   chronic,	  
due	   to	   improvements	   in	   medication	   and	  
management;	   people	   with	   diabetes	   are	  
living	   longer,	   extending	   the	   time	   that	  
cognitive	   impairments	   will	   affect	   their	  
functioning.	   The	   excessive	   CVD	   mortality	  
rate	  associated	  with	  diabetes	  decreased	  by	  
60%	  as	  compared	  to	  the	  rate	  found	  in	  non-­‐
diabetic	   patients	   with	   the	   mortality	   rate	  
from	   all	   causes	   having	   declined	   by	   44%	  
within	   the	   same	   period3.	   While	   these	  
statistics	   are	   a	   reason	   for	   optimism,	   much	  
needs	  to	  be	  done	  to	  address	  the	  social	  and	  
individual	   effects	   on	   the	   long-­‐term	   survival	  
of	   diabetics	   with	   neurodegenerative	  
diseases	   and	   cognitive	   impairments,	  
whether	  related	  to	  their	  diabetes	  or	  caused	  
by	  other	  factors.	  
Unsurprisingly,	   cognitive	   impairment	   has	  
been	   shown	   to	   be	   more	   prevalent	   in	  
countries	  with	  a	   large	  population	  of	  elderly	  
people.	   In	   a	   2004	   study,	  Gregg	  et	   al	   found	  
that	   diabetes	   led	   to	   significant	   cognitive	  
decline	   in	   older	   women4.	   Women	   with	  
diabetes	   were	   found	   to	   have	   between	   57	  
and	   114	   percent	   greater	   chance	   of	   having	  
cognitive	   impairments4.	   MacKnight	   and	  
colleagues	   found	   that	   diabetes	   caused	   an	  
increase	  in	  cognitive	  impairment	  in	  vascular	  
Dementia5.	  Countries	  including	  China	  having	  
365	   million	   elderly	   people	   in	   2005,	   India	  
with	   81	  million	   elderly,	   and	   Indonesia	  with	  
8.5%	   of	   their	   240	   million	   people	   being	   60	  
years	   or	   older,	   are	   examples	   of	   countries	  
experiencing	  this	  problem6.	   	  Studies	  predict	  
that	   there	   will	   be	   a	   likely	   rise	   in	   the	  
prevalence	  of	  cognitive	  impairments.	  
In	  China,	  Pei	  and	  Wan	   found	  a	   relationship	  
between	   cognitive	   function	   and	   glucose	  
tolerance7.	   In	   a	   six-­‐nation	   study,	   which	  
included	   South	   American	   countries,	   China	  
and	   India,	   and	   with	   over	   15,000	   subjects	  
assessed,	   Sosa	   and	   colleagues8	   found	   a	  
statistically	   significant	   difference	   in	  
dementia	   rates,	  with	  Peru	  and	   India	  having	  
much	  higher	  rates	  of	  amnesic	  mild	  cognitive	  
impairment	   (MCI),	   more	   than	   double	  
prevalence	   of	   the	   others	   in	   the	   study.	  
Anjana	  et	  al	  also	  found	  much	  higher	  rates	  of	  
diabetes	   in	   India9.	   South	   Asians	   seem	  
particularly	   susceptible	   to	   cognitive	  
problems.	  
While	   Diabetes	   and	   Alzheimer’s	   have	   been	  
determined	  to	  be	  two	  of	  the	  most	  common	  
causes	   of	   dementia	   in	   the	   world,	   medical	  
personnel	   do	   not	   routinely	   screen	   diabetic	  
patients	  for	  cognitive	  impairment.	  In	  a	  five-­‐
year	   longitudinal	   study,	   patients	   without	  
baseline	   cognitive	   impairment	   were	  
assessed	  for	  the	  association	  of	  diabetes	  and	  
incident	   dementia.	   	   Even	   though	   those	  
patients	  with	  diabetes	  at	  base	  line	  showed	  a	  
higher	   incidence	   of	   vascular	   cognitive	  
impairment	   and	   dementia5.	   Novak	   et	   al	  
found	   that	  diabetics	  had	  exaggerated	  brain	  
vasoconstriction	   reactivity	   and	   more	  
atrophy	   than	   nondiabetic	   patients10.	   In	  
addition,	   these	   diabetic	   brain	   impairments	  
were	   related	   to	   depression	   and	   slower	  
walking.	   Regional	   brain	   analysis	   showed	  
that	   elevated	   levels	   of	   the	   endothelial	  
integrity	   markers	   sVCAM	   (soluble	   vascular	  
cell	  adhesion	  molecule)	  and	  sICAM	  (soluble	  
intracellular	   cell	   adhesion	   molecule)	   were	  
linked	   to	   exaggerated	   vasoconstriction,	  
blunted	  vasodilation,	  and	   increased	  cortical	  
atrophy	   in	   the	   frontal,	   temporal,	   and	  
parietal	   lobes.	   	   These	   results	   indicate	   a	  
potential	   causative	   relationship	   between	  
cognitive	   impairment	   and	   brain	  
functionality	  of	  diabetics.	  
Ohara	   et	   al	   conducted	   a	   study	   of	  
community-­‐dwelling,	   dementia-­‐free	  
subjects	   aged	   60	   or	   older	   who	   underwent	  
an	   oral	   glucose	   tolerance	   test	   (OGTT)	   to	  
ascertain	   a	   diabetic	   diagnosis	   and	   were	  
followed	   for	   15	   years11.	   Using	   detailed	  
neuroimaging	   and	   autopsies,	   the	  
association	   between	   glucose	   tolerance	  
levels	   and	   the	   development	   of	   dementia	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could	   be	   measured	   at	   the	   statistically	  
significant	   level.	   In	   summary,	   it	   was	  
determined	   that	   the	   incidence	   of	   all-­‐cause	  
dementia,	   AD	   and	   vascular	   disease	   (VaD)	  
was	   significantly	   higher	   with	   diabetes	   than	  
in	   those	   within	   the	   community	   that	   had	  
normal	   glucose	   tolerance,	   lending	   support	  
to	   the	   theory	   that	  diabetes	   serves	  as	  a	   risk	  
factor	  for	  some	  subtypes	  of	  dementia11.	  
	  
IMPORTANCE	   OF	   DISCOVERING	  
TRIGGERS	  OF	  BEHAVIORAL	  CHANGE	  
Successful	   diabetes	   interventions	   remain	  
dependent	   upon	   patients	   being	   compliant	  
with	   medication	   (insulin	  
administration/taking	   oral	   medication),	  
exercise	   and	   diet	   as	   recommended	   by	   the	  
health	   care	   professionals.	   	   	   Owing	   to	   the	  
chronic	   nature	   of	   illness,	   a	   patient	  
diagnosed	   with	   diabetes	   is	   told	   to	   adhere	  
and	   follow	  a	  highly	   regimented	   lifestyle	   for	  
the	   remainder	   of	   their	   lifetime.	   A	   complex	  
process	   of	   both	   behavioral	   self-­‐regulation	  
and	   ongoing-­‐active	   complex	   decision	  
making	  helps	  determine	  a	  patient’s	  abilities	  
to	   adhere	   or	   comply	  with	   regimens	   on	   the	  
consistent	   basis,	   critical	   to	   success12.	   	   This	  
expectation	   of	   multiple	   compliances	   (diet,	  
lifestyle,	   medication)	   with	   complex	   tasks,	  
made	   by	   health	   care	   professionals	   and	  
family	  members,	  may	   grossly	   overestimate	  
their	   abilities	   to	   comply	   for	   those	  who	   are	  
also	   suffering	   from	   cognitive	   impairment,	  
and	   doom	   them	   to	   repeated	   failures	  
creating	   a	   learned	   helplessness	   regarding	  
controlling	  their	  disorders.	  
	  
THEORIES	   OF	   TRIGGERS	   OF	  
BEHAVIORAL	  CHANGE	  &	  COMPLIANCE	  
Medication,	   lifestyle	   and	   diet	   compliances	  
continue	   to	   be	   major	   concerns	   in	   fighting	  
diabetes,	   but	   these	   compliances	   are	   based	  
upon	   both	   cognition	   and	   Health	   Self	  
Efficacy.	   In	   order	   for	   patients	   to	   comply	  
consistently,	   they	   must	   believe	   that	   first	  
that	   they	   are	   indeed	   ill,	   and	   secondly	   that	  
these	  compliance	  behaviors,	  which	  can	  cost	  
effectively,	   help	   them.	   By	   cost	   patients	  
include,	   time	   needed,	   taste	   of	   food,	   the	  
social	   consequences	   of	   eating	   separate	  
diets	   and	   other	   factors	   which	   health	   care	  
professionals	  typically	  do	  not	  think	  of	  when	  
making	   their	   recommendations.	   	   Patients	  
must	   have	   a	   strong	   sense	   of	   Health	   Self	  
Efficacy,	   meaning	   simply	   their	   actions	   and	  
sacrifices	   have	   a	   significant	   effect	   of	   their	  
health	   outcomes13.	   It	   must	   be	   both	   a	  
personal	   and	   daily	   fight.	   	   Research	   has	  
demonstrated	   that	   belief	   in	   health	   self-­‐
efficacy	   regarding	   diet	   enables	   patients	   to	  
better	  control	  their	  diabetes14,	  exercise	  and	  
glucose-­‐testing15-­‐17.	   	   Intervention	   programs	  
using	   self-­‐efficacy	   and	   with	   it	   the	   related	  
theoretical	   construct	   of	   Locus	   of	   Control	  
continue	   to	   play	   key	   roles	   in	   predicting	  
behavioral	  change	  in	  Type	  2	  Diabetes	  and	  in	  
instituting	  that	  change18,19.	  Since	  medication	  
non-­‐compliance	   has	   been	   shown	   to	   be	  
related	   to	   Health	   Self	   Efficacy	   in	   patients	  
with	   type	   II	   diabetes,	   perceived	   behavioral	  
control	   could	   explain	   greater	   adherence	   to	  
medication,	   exercise	   and	   dietary	  
behaviors20.	  
Another	   theoretical	   underpinning	   of	  
compliance	  in	  diabetes	  is	  the	  The	  Theory	  of	  
Planned	   Behavior	   (TPB).	   TPB	   which	  
theorizes	   that	   behavior	   can	   be	   influenced	  
by:	   (a)	   Attitude	   towards	   the	   behaviour	  
(some	   behaviors	   are	   viewed	   as	   favorable	  
and	   others	   unfavorable),	   (b)	   Subjective	  
norm	   (perceived	   social	   pressure	   which	  
affects	   diet	   particularly	   in	   social	   situations,	  
and	   (c)	   Perceived	   behavioral	   control	   which	  
is	   similar	   to	   Health	   Self	   Efficacy.	   	   In	   one	  
study	  TPB	  model	  has	  accounted	   for	  46%	  of	  
variance	   in	   behavioral	   intention	   and	   a	   full	  
57%	  of	  variance	  in	  self-­‐monitoring	  behavior	  
done	   by	   patients.	   	   When	   a	   hierarchical	  
regression	   analysis	   was	   conducted	   it	  
showed	   that	   past	   behavior,	   and	   the	  
difficulty	   experienced,	   were	   the	   strongest	  
predictors	   of	   self-­‐monitoring	   blood	   glucose	  
levels	  in	  diabetics21.	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HEALTH	  SELF	  EFFICACY	  
Studies	  have	  also	  shown	  that,	  patients	  who	  
believed	   in	   their	   ability	   to	   control	   diabetes	  
demonstrated	   better	   self-­‐care	   in	   the	   areas	  
of	   diet14,	   exercise	   and	   glucose-­‐testing15,22.	  
Treatment	   control	   perceptions	   have	   also	  
been	   found	   to	   be	   associated	   with	  
glycosylated	   haemoglobin	   levels	   (HbA1C)15.	  
Hierarchical	   multiple	   linear	   regression	  
analysis	   revealed	   illness	   representations	  
accounted	   for	   12%	   of	   the	   variance	   in	  
glycosylated	   hemoglobin	   (HbA1c)	   levels	   of	  
adult	   type	   2	   diabetic	   patients23.	  	  
Intervention	   programs	   developed	   to	   assess	  
health	   self-­‐efficacy	   of	   diabetics,	   focus	   on	  
the	   positive,	   desirable	   outcomes	   of	  
adhering	   to	   diabetes	   management	  
behaviors.	  The	  incorporation	  of	  the	  concept	  
of	   self-­‐efficacy	   into	   almost	   all	   major	  
theories	   of	   behavior	   is	   further	   evidence	   of	  
its	   important	   role	   in	   the	   behavior	   change	  
process18.	  
In	   patients	  with	   type	   II	   diabetes,	   perceived	  
behavioral	   control	   could	   explain	   greater	  
adherence	   to	   medication	   taking	   than	   to	  
exercise	  and	  dietary	  behavior16.	  This	  finding	  
indicates	   the	   need	   to	   consider	   a	   patient’s,	  
past	   behavior,	   what	   the	   patient	   is	   capable	  
of	   and	   what	   is	   feasible	   for	   the	   patient	   in	  
treatment	   customization.	   In	   fact,	   there	   is	  
much	   similarity	   between	   Ajzen’s	   perceived	  
behavioral	   control	   (focus	   on	   ease	   and	  
difficulty	   in	   performing	   behavior)	   and	  
Bandura’s	   construct	   of	   self-­‐efficacy	   (belief	  
in	  one’s	  ability	  to	  perform	  the	  behavior).	  
	  
COGNITIVE	  AND	  HEALTH	  SELF	  EFFICACY	  
SCREENING	  
The	   ongoing	   need	   for	   a	   quality	   screening	  
tool	  or	  battery	  to	  discover	  cognitive	  deficits	  
and	   Health	   Self	   Efficacy	   cannot	   remain	  
simply	   theoretical,	   since	   fully	   one	   third	   of	  
adults	   with	   diabetes	   have	   shown	   evidence	  
of	   mild	   cognitive	   impairment,	   and	  
researchers	   are	   unsure	   as	   to	   what	  
percentage	   have	   low	   Health	   Self	   Efficacy,	  
but	  judging	  by	  compliance	  numbers	  it	  is	  not	  
insignificant.	   Impairment	   in	   these	   areas	  
interferes	   with	   a	   number	   of	   processes	  
including	   their	   likelihood	   to	   participate	   in	  
exercise	   programs,	   belief	   in	   ability	   to	   get	  
better,	   Quality	   of	   Life,	   basic	   self-­‐care,	   and	  
medication	   along	  with	   diet	   compliance24-­‐27.	  	  	  	  
A	   Critchley	   et	   al	   study	   suggests	   that	   one	  
way	   to	   get	   around	   these	   deficits	   in	  
cognition	   and	   to	   increase	   changes	   in	  
behavior	   is	   to	   use	   group	   activities28.	   Group	  
activities	   likely	   better	   reinforce	   changes	   in	  
those	  with	  cognitive	  impairment	  due	  to	  the	  
multisensory	   and	   social	   stimulation	   of	   the	  
group	   creating	   more	   useful	   behavioral	  
changes28.	   And	   group	   activities	   may	   be	   a	  
cost	   effective	   intervention,	   perhaps	   run	   by	  
paraprofessionals	   who	   have	   had	   some	  
success	   in	   managing	   their	   own	   diabetes.	  
Obviously,	   other	   strategies	   need	   to	   be	  
tested	  and	  success	  or	  failure	  measured.	  
Cognitive	   impairment	   related	   to	   cause	   by	  
diabetes	   remains	   an	   under-­‐addressed	  
problem,	  by	  both	  clinicians	  and	  intervention	  
researchers.	   The	   lack	   of	   recognition	   of	   the	  
problem	   by	   primary	   care	   practitioners	  
increases	   the	   chances	   that	   they	   will	   not	  
perform	   the	   necessary	   evaluations	   for	   the	  
condition.	  This	   lack	  of	  evaluation	   interferes	  
not	   only	   with	   the	   ability	   of	   a	   clinician	   to	  
monitor	   the	  condition	   in	  his	  or	  her	  patient,	  
but	  also	  with	  his	  or	  her	  ability	  to	  judge	  what	  
interventions	   are	   working	   and	   how	   to	  
reevaluate	   the	   treatment	   of	   a	   patient	  with	  
impaired	  cognitive	  functioning	  and	  patient’s	  
own	   ability	   to	   evaluate	   their	   progress29.	  	  
Understanding	  how	  to	  increase	  compliances	  
by	   understanding	   the	   patient’s	   cognition	  
and	  Health	  Self	  Efficacy	  are	  the	  only	  ways	  to	  
make	   progress	   in	   this	   critical	   area30.	  
Clinicians	  and	  researchers	  need	   to	  begin	   to	  
view	   	   	   diabetic	   cognitive	   impairment	   and	  
impaired	   Self	   Efficacy	   as	   problems,	   which	  
must	  be	  addressed	  in	  getting	  full	  treatment	  
compliances.	   	   	   In	   addition	   clinicians	   must	  
keep	   in	  mind	   that	   not	   all	   cultures	   respond	  
the	   same	   way	   to	   attempts	   to	   influence	  
various	   types	   of	   compliance31.	   Intervention	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must	  be	  tried	  measuring	  success	  and	  failure	  
and	   tracking	   cultural,	   gender,	   and	   age	  
differences.	  
	  
ACTION	  PLAN	  FOR	  INTERVENING	  
Biessels	  et	  al32	  have	  called	  for	  improvement	  
in	   research	   in	   this	   area,	   since	   in	   their	  
metaanalysis	  both	  statistical	  and	  theoretical	  
foundations	   are	   found	   in	   the	   interplay	  
between	   and	   amongst	   cognition,	   self-­‐
efficacy	   and	   compliance.	   The	   first	   step	   in	  
doing	  this	  is	  to	  recognize	  these	  impairments	  
affect	   compliance.	   	   Secondly,	   they	   can	   be	  
easily	   measured.	   Third,	   once	   discovered,	  
intervention	  needs	  to	  be	  actively	  attempted	  
and	  success	  or	  failure	  measured.	  	  	  
With	   the	   growing	   number	   of	   individuals	  
affected	  by	  diabetes	  with	  very	  poor	  rates	  of	  
compliance,	   it	   is	   important	   to	   expand	  
research	   in	  order	   to	   improve	   interventions.	  	  
With	   early	   detection	   of	   cognitive	  
impairment	   and	   impaired	   Health	   Self	  
Efficacy,	   health	   professionals	   can	   provide	  
ways	   to	   slow	   down	   the	   development	   of	  
diabetic	   dementia,	   but	   it	   cannot	   be	   done	  
unless	   HSE	   is	   taken	   into	   account.	   Health	  
care	   professionals	   can	   respond	   to	   the	  
increased	  need	  for	  more	  effective	  screening	  
methods	   by	   creating	   brief	   test	   batteries,	  
which	  aid	   in	  making	  appropriate	   treatment	  
plans	   for	   patients,	   and	   then	   using	   those	  
plans	   and	   repeated	   testing	   to	   improve	  
compliance	   and	   patient	   outcomes.	  	  	  
Clinicians	   would	   not	   think	   of	   treating	   a	  
diabetic	   without	   regular	   testing	   of	   blood	  
sugar	   levels,	   how	   then	   is	   it	   possible	   to	   not	  
test	   for	   both	   cognitive	   impairment	   and	  
impairment	   in	   Health	   Self	   Efficacy	   both	   of	  
which	   affect	   the	   compliances	   which	   help	  
manage	   the	   sugar	   that	   is	   being	   tested	   for.	  	  
Lastly,	   due	   to	   the	   extent	   of	   the	   disorder	  
perhaps	   it	   is	   time	   to	   study	   Physicians	   and	  
other	   health	   care	   professionals	   in	   terms	   of	  
their	   self-­‐efficacy.	   	   Success	   requires	   that	  
they	  be	  engaged	  and	  have	  a	  sense	  that	  their	  
interventions	   are	   being	   followed	   to	   some	  
extent.	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